We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
A 14-year-old MN DSH cat was presented for chronic weightloss despite moderate thyroid regulation, with a history of known hyperthyroidism on Methimazole.
A 14-year-old MN DSH cat was presented for chronic weightloss despite moderate thyroid regulation, with a history of known hyperthyroidism on Methimazole.
cecal carcinoma, lymphoma, granulomatous disease or less likely dry form FIP
An ileocecal mass was noted and was mixed, hypoechoic and irregular measuring 2.5 x 1.9 cm. Variable small intestinal thickening was noted elsewhere with regional mesenteric lymphadenopathy. The ileocecal mass appeared to be deriving from the proximal cecum. Regional lymph nodes were enlarged and measured 1.0 x 0.5 cm with reactive mesentery. The mass derived from the cecum and is potentially resectable; however, given the lymph node involvement regional spread is probable.
Ultrasound-guided FNA of the cecal mass and lymph nodes would be recommended if possible. Otherwise, surgical approach to ileocecocolic resection, lymph node removal and biopsies would be indicated. Differentials include cecal carcinoma, lymphoma, granulomatous disease or less likely dry form FIP. Treatment for chronic cystitis would also be warranted over a 4-6 week period. Ursodiol therapy would be recommended over the next 4-6 weeks.
Ultrasound-guided FNA of the cecal mass and lymph nodes would be recommended if possible.
